Quick answers
- What is Vyvanse?
- Vyvanse is a brand name of Lisdexamfetamine dimesylate, a prescription medicine. The FDA NDC Directory lists 13 Vyvanse products in 13 strengths and forms.
- Who makes Vyvanse?
- Takeda Pharms USA holds the FDA application for Vyvanse (NDA021977, approved February 23, 2007).
- Is there a generic or store brand of Vyvanse?
- Yes. The FDA NDC Directory lists 160 other products with the same active ingredients, strength and form as a Vyvanse product, 160 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Vyvanse?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 13 Vyvanse strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Vyvanse been recalled?
- FDA enforcement reports list 1 recall of Vyvanse products; the newest started September 2, 2016. A recall usually concerns specific lots, not every product.
What Vyvanse is
Each Vyvanse product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lisdexamfetamine dimesylate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lisdexamfetamine dimesylate 10 mg capsule (oral) | Vyvanse | 15 products, 15 companies | DailyMed |
| lisdexamfetamine dimesylate 10 mg tablet, chewable (oral) | Vyvanse | 6 products, 6 companies | DailyMed |
| lisdexamfetamine dimesylate 20 mg capsule (oral) | Vyvanse | 18 products, 18 companies | DailyMed |
| lisdexamfetamine dimesylate 20 mg tablet, chewable (oral) | Vyvanse | 6 products, 6 companies | DailyMed |
| lisdexamfetamine dimesylate 30 mg capsule (oral) | Vyvanse | 19 products, 18 companies | DailyMed |
| lisdexamfetamine dimesylate 30 mg tablet, chewable (oral) | Vyvanse | 6 products, 6 companies | DailyMed |
| lisdexamfetamine dimesylate 40 mg capsule (oral) | Vyvanse | 18 products, 18 companies | DailyMed |
| lisdexamfetamine dimesylate 40 mg tablet, chewable (oral) | Vyvanse | 6 products, 6 companies | DailyMed |
| lisdexamfetamine dimesylate 50 mg capsule (oral) | Vyvanse | 18 products, 18 companies | DailyMed |
| lisdexamfetamine dimesylate 50 mg tablet, chewable (oral) | Vyvanse | 6 products, 6 companies | DailyMed |
| lisdexamfetamine dimesylate 60 mg capsule (oral) | Vyvanse | 18 products, 18 companies | DailyMed |
| lisdexamfetamine dimesylate 60 mg tablet, chewable (oral) | Vyvanse | 6 products, 6 companies | DailyMed |
| lisdexamfetamine dimesylate 70 mg capsule (oral) | Vyvanse | 18 products, 18 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lisdexamfetamine dimesylate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| lisdexamfetamine dimesylate 10 mg capsule | Brand: Vyvanse | $12.35 per capsule Generic of the same strength and form: $2.54 per capsule |
| lisdexamfetamine dimesylate 10 mg tablet, chewable | Brand: Vyvanse | $12.35 per tablet Generic of the same strength and form: $3.79 per tablet |
| lisdexamfetamine dimesylate 20 mg capsule | Brand: Vyvanse | $12.35 per capsule Generic of the same strength and form: $2.49 per capsule |
| lisdexamfetamine dimesylate 20 mg tablet, chewable | Brand: Vyvanse | $12.34 per tablet Generic of the same strength and form: $4.32 per tablet |
| lisdexamfetamine dimesylate 30 mg capsule | Brand: Vyvanse | $12.34 per capsule Generic of the same strength and form: $2.88 per capsule |
| lisdexamfetamine dimesylate 30 mg tablet, chewable | Brand: Vyvanse | $12.35 per tablet Generic of the same strength and form: $3.87 per tablet |
| lisdexamfetamine dimesylate 40 mg capsule | Brand: Vyvanse | $12.35 per capsule Generic of the same strength and form: $2.66 per capsule |
| lisdexamfetamine dimesylate 40 mg tablet, chewable | Brand: Vyvanse | $12.35 per tablet Generic of the same strength and form: $4.17 per tablet |
| lisdexamfetamine dimesylate 50 mg capsule | Brand: Vyvanse | $12.35 per capsule Generic of the same strength and form: $2.73 per capsule |
| lisdexamfetamine dimesylate 50 mg tablet, chewable | Brand: Vyvanse | $12.35 per tablet Generic of the same strength and form: $3.68 per tablet |
| lisdexamfetamine dimesylate 60 mg capsule | Brand: Vyvanse | $12.35 per capsule Generic of the same strength and form: $2.61 per capsule |
| lisdexamfetamine dimesylate 60 mg tablet, chewable | Brand: Vyvanse | $12.36 per tablet Generic of the same strength and form: $3.58 per tablet |
| lisdexamfetamine dimesylate 70 mg capsule | Brand: Vyvanse | $12.35 per capsule Generic of the same strength and form: $2.61 per capsule |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Vyvanse
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Vyvanse products.
- Takeda Pharmaceuticals America, Inc.13 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
September 2, 2016 · Class III · Terminated · D-0006-2017
Presence of Foreign Tablets/Capsules
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10 — Shire
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.